https://www.biopharmawatch.com/news/MRNA/moderna-third-quarter-2026-financial-results BiopharmaWatch en 2026-11-06T00:00:00.000Z Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026 https://www.biopharmawatch.com/news/CLPT/clearpoint-neuro-announces-third-quarter-results-2026 BiopharmaWatch en 2026-10-28T00:00:00.000Z ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, 2026 https://www.biopharmawatch.com/news/SYRE/spyre-therapeutics-uegw-2026-presentations BiopharmaWatch en 2026-10-18T13:30:00.000Z Spyre Therapeutics Announces Clinical and Preclinical Data Presentations at United European Gastroenterology Week (UEGW) 2026 https://www.biopharmawatch.com/news/ALGN/align-technology-patent-infringement-case-angelalign BiopharmaWatch en 2026-10-17T01:11:00.000Z Align Technology Wins Significant Patent Infringement Case Against Angelalign at Unified Patent Court https://www.biopharmawatch.com/news/ANNX/annexon-reports-inducement-grants-new-employees-nasdaq-listing-rule-5635-20261016 BiopharmaWatch en 2026-10-16T21:34:00.000Z Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) https://www.biopharmawatch.com/news/IOVA/iovance-biotherapeutics-reports-inducement-grants-nasdaq-listing-rule-5635-c-20261016 BiopharmaWatch en 2026-10-16T21:15:00.000Z Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) https://www.biopharmawatch.com/news/ATNM/actinium-pharmaceuticals-inducement-grants-new-employees BiopharmaWatch en 2026-10-16T21:00:00.000Z Actinium Pharmaceuticals Announces Inducement Grants to New Employees